Australia markets closed

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.08300.0000 (0.00%)
At close: 04:11PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2021
30/06/2020
30/06/2019
30/06/2018
Total revenue
9,969
8,353
5,694
4,098
4,797
Cost of revenue
1,599
1,602
1,678
1,252
1,596
Gross profit
8,370
6,751
4,016
2,846
3,201
Operating expenses
Research development
888
1,456
3,308
2,958
2,979
Selling general and administrative
22,832
22,972
20,965
21,355
24,301
Total operating expenses
29,207
29,824
29,573
29,858
33,840
Operating income or loss
-20,837
-23,073
-25,557
-27,012
-30,639
Total other income/expenses net
1,729
2,437
4,189
2,696
3,063
Income before tax
-19,130
-20,667
-21,329
-23,945
-27,132
Income tax expense
58
39
48
51
42
Income from continuing operations
-19,188
-20,706
-21,377
-23,996
-27,174
Net income
-19,188
-20,706
-21,377
-24,123
-27,174
Net income available to common shareholders
-19,188
-20,706
-21,377
-24,123
-27,174
Basic EPS
-
-0.02
-0.04
-0.06
-0.07
Diluted EPS
-
-0.02
-0.04
-0.06
-0.07
Basic average shares
-
1,202,320
595,167
397,437
395,144
Diluted average shares
-
1,202,320
595,167
397,437
395,144
EBITDA
-
-21,373
-24,121
-26,330
-30,179